Our result was consistent with the previous evidence that TGFβ1 shows higher and more widespread upregulation in the tumor microenvironment than the other two isoforms and is more robustly associated with failure of immune checkpoint inhibitor in patients with cancer (24). The gene discussed is TGFB1; the disease is neoplasm.